reiterateBBIOfinnhub
HC Wainwright & Co. Reiterates Buy Rating on BridgeBio Pharma, Inc. (BBIO)
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on BridgeBio Pharma, Inc. (NASDAQ:BBIO) on July 13, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on BridgeBio Pharma, Inc. (NASDAQ:BBIO) on July 13, 2026.
Read moreRating Change Mizuho analysts reiterated a Outperform rating on Medpace Holdings, Inc. (NASDAQ:MEDP) on July 13, 2026. Market Context Medpace Holdings, Inc.
Read moreRating Change Rothschild & Co analysts initiated coverage on Fastenal Company (NASDAQ:FAST) with a Buy rating on July 13, 2026. Market Context Fastenal Company operates in the…
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on SBA Communications Corporation (NASDAQ:SBAC) on July 10, 2026. Market Context SBA Communications Corporation…
Read moreRating Change B of A Securities analysts reiterated a Neutral rating on United Therapeutics Corporation (NASDAQ:UTHR) on July 10, 2026. Market Context United Therapeutics…
Read moreRating Change Raymond James analysts initiated coverage on BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU) with a Outperform rating on July 10, 2026. Market…
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Tradeweb Markets Inc. (NASDAQ:TW) on July 10, 2026. Market Context Tradeweb Markets Inc.
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Market Perform rating on T. Rowe Price Group, Inc. (NASDAQ:TROW) on July 10, 2026.
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on T. Rowe Price Group, Inc. (NASDAQ:TROW) on July 10, 2026.
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Intercontinental Exchange, Inc. (NYSE:ICE) on July 10, 2026. Market Context Intercontinental Exchange,…
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on CME Group Inc. (NASDAQ:CME) on July 10, 2026. Market Context CME Group Inc.
Read moreRating Change B of A Securities analysts reiterated a Buy rating on Bristol-Myers Squibb Company (NYSE:BMY) on July 10, 2026. Market Context Bristol-Myers Squibb Company operates…
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Robinhood Markets, Inc. (NASDAQ:HOOD) on July 10, 2026. Market Context Robinhood Markets, Inc.
Read moreRating Change UBS analysts reiterated a Buy rating on Spotify Technology S.A. (NYSE:SPOT) on July 10, 2026. Market Context Spotify Technology S.A.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on Chubb Limited (NYSE:CB) on July 10, 2026. Market Context Chubb Limited operates in the Financial Services…
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Chubb Limited (NYSE:CB) on July 10, 2026. Market Context Chubb Limited operates in the Financial…
Read moreRating Change Barclays analysts reiterated a Overweight rating on KKR & Co. Inc. (NYSE:KKR) on July 10, 2026.
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Medtronic plc (NYSE:MDT) on July 10, 2026. Market Context Medtronic plc operates in the Healthcare sector. The stock…
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on The Progressive Corporation (NYSE:PGR) on July 10, 2026. Market Context The Progressive Corporation…
Read moreRating Change JP Morgan analysts reiterated a Neutral rating on Union Pacific Corporation (NYSE:UNP) on July 10, 2026. Market Context Union Pacific Corporation operates in the…
Read more